| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12
|
|
ADD2
|
adducin 2 (beta)
|
|
ADGRE2
|
adhesion G protein-coupled receptor E2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AK2
|
adenylate kinase 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
APCS
|
amyloid P component, serum
|
|
APOA4
|
apolipoprotein A-IV
|
|
AQP9
|
aquaporin 9
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
ARHGAP32
|
Rho GTPase activating protein 32
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARRB1
|
arrestin, beta 1
|
|
AZU1
|
azurocidin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD177
|
CD177 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD63
|
CD63 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLU
|
clusterin
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CST3
|
cystatin C
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSG
|
cathepsin G
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYTH1
|
cytohesin 1
|
|
DCN
|
decorin
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DNASE1
|
deoxyribonuclease I
|
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
|
EDN1
|
endothelin 1
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
F10
|
coagulation factor X
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASTK
|
Fas-activated serine/threonine kinase
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FLOT1
|
flotillin 1
|
|
FLOT2
|
flotillin 2
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
GABARAPL2
|
GABA(A) receptor-associated protein-like 2
|
|
GDF15
|
growth differentiation factor 15
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GLRA2
|
glycine receptor, alpha 2
|
|
GPR132
|
G protein-coupled receptor 132
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HMGB1
|
high mobility group box 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL17B
|
interleukin 17B
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAGN1
|
jagunal homolog 1 (Drosophila)
|
|
JAK2
|
Janus kinase 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
KDR
|
kinase insert domain receptor
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LBR
|
lamin B receptor
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP1S
|
microtubule-associated protein 1S
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR146A
|
microRNA 146a
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYLK
|
myosin light chain kinase
|
|
N4BP2L2
|
NEDD4 binding protein 2-like 2
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCKAP1L
|
NCK-associated protein 1-like
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NKRF
|
NFKB repressing factor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
OCLN
|
occludin
|
|
ORM1
|
orosomucoid 1
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PADI1
|
peptidyl arginine deiminase, type I
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PGLYRP1
|
peptidoglycan recognition protein 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLG
|
plasminogen
|
|
PML
|
promyelocytic leukemia
|
|
PPAPDC2
|
phosphatidic acid phosphatase type 2 domain containing 2
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PRAM1
|
PML-RARA regulated adaptor molecule 1
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRTN3
|
proteinase 3
|
|
PSD
|
pleckstrin and Sec7 domain containing
|
|
PSMC1
|
proteasome (prosome, macropain) 26S subunit, ATPase, 1
|
|
PSMD3
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RADIL
|
Ras association and DIL domains
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RPS19
|
ribosomal protein S19
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAA1
|
serum amyloid A1
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIGLEC14
|
sialic acid binding Ig-like lectin 14
|
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRPB1
|
signal-regulatory protein beta 1
|
|
SLC22A17
|
solute carrier family 22, member 17
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SPAM1
|
sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
STOM
|
stomatin
|
|
SYK
|
spleen tyrosine kinase
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TP73
|
tumor protein p73
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VNN2
|
vanin 2
|
|
VPS45
|
vacuolar protein sorting 45 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF1
|
WAS protein family, member 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
